|
|||||
|
|
Arylaminoethyl amides as inhibitors of the cysteine protease cathepsin K-investigating P1' substituents |
|
| Authors: | Altmann Eva Green Jonathan Tintelnot-Blomley Marina |
| Affiliation: | Arthritis & Bone Metabolism Therapeutic Area, Novartis Pharma AG, CH-4002, Basel, Switzerland, eva.altmann@pharma.novartis.com |
| Abstract: | Modeling, synthesis and in vitro activities of a series of arylaminoethyl amide based inhibitors of the cysteine protease cathepsin K are described. |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |